Biotech: Page 33
-
Saudi Arabia: Oil Wealth Opens Doors to Health and Life Sciences
Saudi Arabia: Oil Wealth Opens Doors to Health and Life Sciences By Kim Ribbink Its wealth, growing population, investment in health and the life sciences, and high rates of diseases such as diabetes, make Saudi Arabia an exciting market for pharma companies. Saudi Arabia is perhaps best known fo...
By Kim Ribbink • Jan. 28, 2013 -
Talent Pool
Biotech Pool Dr. Michelle BERREY Chimerix Appoints CMO Chimerix, a biotechnology company developing orally available antiviral therapeutics, has named Michelle Berrey, M.D., chief medical officer. Before joining Chimerix, Dr. Berrey was chief medical officer at Pharmasset. Lindsay ROCCO Dendreon ...
By Taren Grom • Jan. 25, 2013 -
Explore the Trendline➔
Stock via Getty ImagesTrendlineOncology
As investments in cancer R&D stay high, waves of innovative new treatments are on the horizon.
By PharmaVoice staff -
What's New
New Healthcare-related Products, Services, and Companies Featured Briefs: Publicis Healthcare Communications Group Launches Publicis Health Media Havas Health Launches New Global Agency Group INC Research Expands Global Consulting Capabilities Cenduit Introduces New Clinical Trial Supply Simulati...
By Taren Grom • Jan. 25, 2013 -
UpFront
Awards… BBK Receives Web Health Award CRA Executives Honored InVivo Co-Founder Receives Award Ogilvy Wins Four Finalist Certificates at the Global Awards Wolters Kluwer Wins KLAS Award INDUSTRY at Large Bristol-Myers Squibb Foundation Supports Returning Veterans Pharmaceutical R&D Costs I...
By Taren Grom • Jan. 25, 2013 -
Letter from the Editor
The Games Companies Play Gamification is not necessarily new to the corporate world, but the technologies that are now available are elevating gaming methodologies to a new level. For those of us who grew up in the era of Pong and Atari home videogames, boy have we come a long way. Wii, which rev...
By Taren Grom • Jan. 25, 2013 -
Talent Pool
Pharmaceutical POOL Melissa Barnes Anne Nobles Lilly Names New Ethics Chief Melissa Barnes has been promoted to chief ethics and compliance officer and senior VP president of enterprise risk management at Eli Lilly and Company. In her new role, Ms. Barnes reports to John Lechleiter, Ph.D., chairm...
By Anne Gray • Dec. 27, 2012 -
Global: Markets
The Continued Influence of Global Markets Across all aspects of the business, the life-sciences industry can no longer afford to think and act locally. From changing demographics, emerging markets increasing in influence, and an increasing focus on both biotech products and generics, pharmaceutic...
By Denise Myshko • Nov. 13, 2012 -
The C-Suite: Executive Insights
Executive Insights CEOs, presidents, and executive management team members from across the industry — pharmaceutical, biotechnology, and service companies — discuss the most crucial factors driving change in the industry, as well as their strategies for meeting the challenges of business in the ...
By Taren Grom • Nov. 13, 2012 -
The Year Ahead: Forging New Paths
Forging New Paths Ever-changing market dynamics will create an industry that is unlike the one we have today. 2013 promises to be as tumultuous as 2012, as the industry looks to contend with the political ping-pong ball that is healthcare. Faced with myriad internal and external pressures, life-s...
By Denise Myshko • Nov. 13, 2012 -
On the Calendar
The Calendar Industry Events and Conferences, including SPECIAL DISCOUNTS Coming ATTRACTIONS Social Media, Mobile & Gaming for Pharma: How To Develop, Monitor, & Execute Digital Strategies To Engage Your Audiences, Strengthen Brand Awareness & Maximize Your Communication & Marketi...
By Taren Grom • Nov. 8, 2012 -
UpFront
Awards… Honored by Working Mother Bayer has been recognized by Working Mother magazine as one of the nation’s 100 best companies for working mothers. This is the ninth time in the past 10 years the company has been recognized on the annual list Clinical Research Advantage Executive Honorod Clinic...
By Taren Grom • Nov. 8, 2012 -
Letter from the Editor
Volume 12 • Number 10 Publisher Lisa Banket Editor Taren Grom Creative Director Marah Walsh Managing Editor Denise Myshko Senior Editor Robin Features Editor Kim Ribbink Contributing Editor Carolyn Gretton Design Associate Ariel Medel National Account Managers Trish Kane, Cathy Tracy WEBCAST?NETW...
By Taren Grom • Nov. 8, 2012 -
Last Word
Developing a Patient-Centric Business Model Rob Bazemore, President of Janssen Biotech, discusses why and how the company is implementing a patient-centric focus throughout all levels of the company. PV: What does being patient-centric mean for Janssen Biotech? Bazemore: Patients are our top pri...
By Rob Basemore • Sept. 27, 2012 -
Talent Pool
Pharmaceutical Pool Dr. Lawrence Bloch Infinity Names Business Chief Lawrence Bloch, M.D., has joined Infinity Pharmaceuticals as executive VP, chief financial officer, and chief business officer. Dr. Bloch is responsible for the company’s corporate, financial, and business development strategies...
By Carolyn Gretton • Sept. 27, 2012 -
Facing the Challenges of Global Product Registration
Facing the Challenges of Global Product Registration Robin Robinson One could say keeping track of global product registrations and staying compliant with regional and international regulations is more difficult than herding cats — if that common phrase used to describe a situation where numerous...
By Robin Robinson • Aug. 30, 2012 -
Insights from the C-Suite: Pharmaceutical Companies
Insights from the C-Suite: Pharmaceutical CompaniesThe pharmaceutical industry is facing a number of well-publicized challenges: increasing generic competition, pricing pressures, innovation hurdles, Wall Street scrutiny, etc. C-suite pharmaceutical executives who were also featured in the Pharma...
By Taren Grom • Aug. 30, 2012 -
Coming of Age: India Grows in Stature
India’s pharmaceutical industry is now the third largest in the world in terms of volume and stands 14th in terms of value. The country’s pharmaceutical market is expected to reach $55 billion in 2020 from $12.6 billion in 2009. And with a population of 1.1 billion, India is predicted to be the m...
By Kim Ribbink • Aug. 30, 2012 -
Talent Pool
Pharmaceutical POOL Dr. Dipak PANIGRAHI Silvia TAYLOR Sucampo Names Executives Global pharmaceutical firm Sucampo Pharmaceuticals has added two VPs to its leadership team. Sucampo has appointed Dipak Panigrahi, M.D., VP, medical affairs. Dr. Panigrahi’s responsibilities include establishing and l...
By Carolyn Gretton • Aug. 30, 2012 -
PharmaVOICE 100 - Who's on the List by Section
The Commanders & Chiefs 10 Adrian Adams Auxilium Pharmaceuticals Rich Altus PDR Network Matt Baker Compass IRB J. Martin Carroll Boehringer Ingelheim Leo Francis, Ph.D. Publicis Healthcare Communications Group Lisa Costantino EMD Serono David de Graaf, Ph.D. Selventa Asaf Evenhaim Crossix Sol...
By Taren Grom • July 28, 2012 -
What's New
What’s New New Healthcare-Related Products, Services, and Companies By Carolyn Gretton Saatchi & Saatchi Science Focuses on Complex Categories Trend: The agency’s name change reflects its vision for the future and its expertise in distilling scientific and market data into compelling brand...
By Carolyn Gretton • July 28, 2012 -
The PV 100 Book Club
Favorite Books Nonfiction Favorites The Innovator‚Äôs Dilemma: The ¬?Revolutionary Book That Will Change the Way You Do Business by Clayton Christensen Play Like a Man, Win Like a Woman: What Men Know About Success that Women Need to Learn by Gail Evans The Business of Being the Best: ¬?Inside th...
By Taren Grom and Kim Ribbink • July 28, 2012 -
2012 PharmaVOICE 100 - Who's on the List by Company
360 Vantage Mario Martinez II Agile Therapeutics Marie Foegh, M.D. Alkermes Elliot Ehrich, M.D. Almac Clinical Technologies Graham Nicholls Amgen Martin VanTrieste, R.Ph. Appature Kabir Shahani The Assay Depot Kevin Lustig, Ph.D. Auxilium Pharmaceuticals Adrian Adams Ayogo Games Michael Fergusson...
By Taren Grom • July 28, 2012 -
Letter from the Editor
Letter from the Editor Inspiration… Try not to become a man of success but a man of value. — Albert Einstein. Einstein might have been describing this year’s PharmaVOICE 100 honorees. This distinguished group of individuals — men and women — are committed to achieving results that lead to the g...
By Taren Grom • July 28, 2012 -
2012 DIA Preview
2012 DIA Preview New tools, services, and products to improve drug development from DIA exhibitors. This special Drug Information Association section highlights news as well as new and innovative products being offered by companies exhibiting at the upcoming 2012 DIA, the 48th Annual Meeting, in ...
By Taren Grom • May 29, 2012 -
It's Time for Mobile: Do You Know Where Your Consumers Are?
By Robin Robinson There are several very solid reasons why the industry should be using mobile technology in its marketing efforts, but the one that stands out above all others is quite simple — mobile is where the consumers are. There are more smartphones than personal computers in the United St...
By PharmaVoice Team • May 29, 2012